00002763611 — Olanzapine Pamoate 300 Mg IM Suspension
Cite this view
HANK Price Transparency. (n.d.). OLANZAPINE PAMOATE 300 MG IM SUSPENSION (NDC 00002763611) negotiated rates. PPMan price-transparency data, derived from CMS-required hospital MRFs. Retrieved , from http://ppman.hank.ai/transparency/code/00002763611?code_type=NDC
“OLANZAPINE PAMOATE 300 MG IM SUSPENSION (NDC 00002763611) negotiated rates.” HANK Price Transparency, http://ppman.hank.ai/transparency/code/00002763611?code_type=NDC. Accessed .
“OLANZAPINE PAMOATE 300 MG IM SUSPENSION (NDC 00002763611) negotiated rates,” HANK Price Transparency, accessed , http://ppman.hank.ai/transparency/code/00002763611?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital machine-readable files (45 CFR 180). See methodology.
Usually $551–$551 (25th–75th percentile) across 1 hospital · 1 payer.
“Negotiated” is the hospital’s negotiated facility rate for this NDC 00002763611 — the consumer-grade median across the country. It covers the facility charge only; the surgeon’s and anesthesiologist’s fees are billed separately.
Per-month price trends are temporarily unavailable while we rebuild them on quality-filtered rates. The medians, percentiles, and per-hospital rates on this page are the quality-filtered figures.
Hospital rates (per row)
Showing consumer-grade rates only. Flagged / outlier filings (excluded from the medians above) are hidden — tick “Show flagged / outlier rates” to include them.
| Hospital | Payer | Plan | Negotiated rate | Gross | Cash | Observed | Source |
|---|---|---|---|---|---|---|---|
| LINDNER CENTER OF HOPE Inpatient | OHIO HEALTH CHOICE | ALL PLANS | $551.34 | $2,756.70 | $1,323.22 | 2026-01-01 | MRF ↗ |